The Long And Short Of Accelerated Approval Accountability In US
• By Michael McCaughan
FDA appears to be accelerating the pace of withdrawing products with missing or failed confirmatory studies. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
